Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CJJD
Upturn stock ratingUpturn stock rating

China Jo-Jo Drugstores Inc (CJJD)

Upturn stock ratingUpturn stock rating
$1.46
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/25/2025: CJJD (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -16.33%
Avg. Invested days 40
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/25/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 9.95M USD
Price to earnings Ratio -
1Y Target Price 7
Price to earnings Ratio -
1Y Target Price 7
Volume (30-day avg) 23644
Beta -0.15
52 Weeks Range 1.29 - 3.39
Updated Date 03/31/2025
52 Weeks Range 1.29 - 3.39
Updated Date 03/31/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.31

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.8%
Operating Margin (TTM) -3.12%

Management Effectiveness

Return on Assets (TTM) -3.98%
Return on Equity (TTM) -29.67%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 30313541
Price to Sales(TTM) 0.07
Enterprise Value 30313541
Price to Sales(TTM) 0.07
Enterprise Value to Revenue 0.21
Enterprise Value to EBITDA 9.06
Shares Outstanding 6178360
Shares Floating 3905877
Shares Outstanding 6178360
Shares Floating 3905877
Percent Insiders 41.3
Percent Institutions 0.37

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

China Jo-Jo Drugstores Inc

stock logo

Company Overview

overview logo History and Background

China Jo-Jo Drugstores Inc., founded in 2003, operates as a retailer and distributor of pharmaceutical products, nutritional supplements, and other healthcare products in China. It has expanded through acquisitions and organic growth, adapting to evolving market demands.

business area logo Core Business Areas

  • Retail Pharmacy Operations: Operates a chain of retail pharmacies selling prescription and over-the-counter drugs, traditional Chinese medicine, nutritional supplements, personal care products, and medical devices.
  • Wholesale and Distribution: Distributes pharmaceutical products and healthcare-related items to other pharmacies, hospitals, and retailers.
  • Online Sales: Sells products through online platforms to reach a wider customer base.

leadership logo Leadership and Structure

The company is led by a board of directors and an executive management team. The organizational structure typically includes departments for retail operations, wholesale distribution, marketing, finance, and administration.

Top Products and Market Share

overview logo Key Offerings

  • Prescription Drugs: Prescription medications dispensed through its pharmacies. Market share data is not readily available. Competitors include other pharmacy chains and hospitals in China.
  • Over-the-Counter (OTC) Drugs: A range of OTC medications for common ailments. Market share data is not readily available. Competitors include other pharmacy chains and supermarkets.
  • Nutritional Supplements: Vitamins, minerals, and other health supplements. Market share data is not readily available. Competitors include other pharmacy chains and health stores.

Market Dynamics

industry overview logo Industry Overview

The Chinese pharmaceutical retail market is large and growing, driven by an aging population, increasing healthcare awareness, and rising disposable incomes. It's a competitive market with domestic and international players.

Positioning

China Jo-Jo Drugstores aims to be a trusted provider of healthcare products and services, leveraging its retail network and distribution capabilities. Its competitive advantages may include its local market knowledge and relationships with suppliers.

Total Addressable Market (TAM)

The Chinese pharmaceutical retail market is estimated to be worth hundreds of billions of USD. China Jo-Jo Drugstores holds a small percentage of the total market, with potential for expansion through strategic initiatives.

Upturn SWOT Analysis

Strengths

  • Established retail network in certain regions of China
  • Distribution capabilities
  • Brand recognition (potentially regional)
  • Experience in the Chinese pharmaceutical market

Weaknesses

  • Limited geographic reach compared to larger competitors
  • Reliance on suppliers for product sourcing
  • Potential regulatory risks in China
  • Smaller market capitalization

Opportunities

  • Expanding into new geographic regions in China
  • Increasing online sales
  • Acquiring smaller pharmacy chains
  • Offering new healthcare services in its pharmacies

Threats

  • Intense competition from larger pharmacy chains
  • Changing government regulations regarding drug pricing and distribution
  • Counterfeit products
  • Economic slowdown in China

Competitors and Market Share

competitor logo Key Competitors

  • LBPS
  • PED
  • SFUN

Competitive Landscape

China Jo-Jo Drugstores Inc. faces intense competition. Its advantage lies in its established network, while its disadvantage is its smaller size compared to larger players. Local market knowledge is an advantage, while brand recognition limitations are a disadvantage.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Historical growth trends cannot be determined due to the lack of publicly available recent and consistent data.

Future Projections: Future projections for China Jo-Jo Drugstores Inc's future growth based on analyst estimates cannot be provided due to the lack of coverage and readily available information.

Recent Initiatives: Recent strategic initiatives undertaken by China Jo-Jo Drugstores Inc cannot be provided due to the lack of publicly available recent and consistent data.

Summary

China Jo-Jo Drugstores Inc. is a small player in a large and competitive market. Its established retail network in certain Chinese regions is a strength, but limited geographic reach and competitive pressures present challenges. While a lack of data makes financial assessment difficult, expanding online and strategic acquisitions could improve its position.

Similar Companies

  • LBPS
  • PED
  • SFUN

Sources and Disclaimers

Data Sources:

  • Company website, SEC filings (where available), Market research reports (where available), General news sources.

Disclaimers:

The information provided is based on publicly available data and may not be entirely accurate or up-to-date. The analysis is for informational purposes only and should not be considered financial advice. Market share and financial data are estimates based on limited data.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About China Jo-Jo Drugstores Inc

Exchange NASDAQ
Headquaters -
IPO Launch date 2008-05-16
Chairman & CEO Mr. Lei Liu M.D.
Sector Healthcare
Industry Pharmaceutical Retailers
Full time employees 939
Full time employees 939

China Jo-Jo Drugstores, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company offers consultation, examination, and treatment of common ailments by licensed doctors in western medicine and TCM at scheduled hours. In addition, it provides treatment for minor ailments, such as sprains, minor lacerations, and dizziness; acupuncture, therapeutic massage, and cupping services; and minor outpatient surgical treatments, including suturing. Further, it offers OTC drugs and nutritional supplements through its website www.dada360.com, as well as sells products through third-party platforms. Additionally, the company distributes third-party pharmaceutical products to trading companies, as well as cultivates and wholesales herbs used for TCM. It operates pharmacies under the Jiuzhou Grand Pharmacy name. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People's Republic of China.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​